The report covers forecast and analysis for the pharmaceutical intermediates market on a global and regional level. The study provides historical data from 2015 to 2017 along with a forecast from 2018 to 2024 based on revenue (USD Million). The study includes drivers and restraints for the pharmaceutical intermediates market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the pharmaceutical intermediates market on a global level.
In order to give the users of this report a comprehensive view of the pharmaceutical intermediates market, we have included competitive landscape and analysis of Porter’s Five Forces model in the market. The study encompasses a market attractiveness analysis, where product type, application, distribution channel, and regional segmentation are benchmarked based on their market size, growth rate, and general attractiveness.
The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments in the market, including acquisitions & mergers, new product launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants in the market on the global and regional basis.
The study provides a decisive view of the pharmaceutical intermediates market by segmenting the market based on product type, application, distribution channel, and regions. All the segments have been analyzed based on present and future trends and the market are estimated from 2018 to 2024.
Based on product type, the pharmaceutical intermediates market is segmented as GMP and Non GMP. Based on the application, the pharmaceutical intermediates market is segmented into antibiotics, antipyretic analgesics, vitamins, and others. Based on the distribution channel, the pharmaceutical intermediates market is segmented as direct sales and distributor.
Increased prevalence of various diseases is one of the major driving factors of pharmaceutical intermediates market. Increased demand for pharmaceuticals coupled with a rise in research and development activities are likely to lead to the innovation of new and advanced products that are expected to promote the growth of pharmaceutical intermediates market. However, stringent regulations are predicted to influence market growth during the forecast period.
The regional segmentation includes the current and forecast demand for the product in North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa that are further divided into major countries, including the U.S., Germany, France, the UK, China, Japan, India, and Brazil. This segment includes demand for pharmaceutical intermediates market based on individual segment and treatment in all the regions and countries.
The report also includes detailed profiles of end players such as Aceto Corporation, Easter Chemical Corporation, BASF SE, A.R. Life Sciences Private Limited, Vertellus Holdings LLC, Lianhetech, Dishman Group, Midas Pharma GmbH, Codexis, Inc., Chemcon Specialty Chemical Pvt. Ltd., Cycle Pharma, Dextra Laboratories Ltd., Sanofi Winthrop Industries S.A., and ZCL Chemicals Ltd.
This report segments the global pharmaceutical intermediates market as follows:
Global Pharmaceutical Intermediates Market: Product Type Segment Analysis
- GMP
- Non GMP
Global Pharmaceutical Intermediates Market: Application Segment Analysis
- Antibiotics.
- Antipyretic analgesics
- Vitamins
- Other
Global Pharmaceutical Intermediates Market: Distribution Channel Segment Analysis
- Direct Sales
- Distributor
Global Pharmaceutical Intermediates Market: Regional Analysis
- North America
- The U.S.
- Europe
- UK
- France
- Germany
- Asia Pacific
- China
- Japan
- India
- Latin America
- Brazil
- Middle East and Africa
